Fact CheckerSign in

NCT04707105Recruiting

Prospective Cohort Study of Intracerebral Hemorrhage

A Prospective Observational Cohort Study in Chinese Patients With Primary Intracerebral Hemorrhage

Source: ClinicalTrials.gov · Last updated 18 Mar 2021 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification,cost-effective ,treatments and prognosis of Chinese hospitalised adult patients with intracerebral hemorrhage.

Status (registry)
Recruiting
Study type
Observational
Enrollment
856 (estimated)
First submitted
11 Jan 2021
Start date
29 Dec 2020
Primary completion date
Dec 2025
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
NCT number
NCT04707105

What you commit to

  • Study type: Observational
  • Planned participants: 856
  • From 29 Dec 2020 to the primary completion date, Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • surgical evacuation of hematoma;

Other illness

  • patients of secondary intracerebral hemorrhage,such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor.
  • isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients;

Other

  • unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI
  • patients cannot be followed up for any reasons.
  • patients death in 24 hours
  • pregnant patients

Who the study is looking for

  • Hospitalized patients over 18 years old of primary intracerebral hemorrhage.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
2nd Affiliated Hospital, School of Medicine at Zhejiang University
Coordinator of this site? Confirm its status
HangzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.